Pathological analysis of abnormal activation for peptidylarginine deiminase in brain
Pathological analysis of abnormal activation for peptidylarginine deiminase in brain
批准号:
17590326
负责人:
KUBO Sachiho
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
瓜氨酸蛋白是翻译后的产物,精氨酸残基在多肽精氨酸脱亚胺酶(PADS)的催化下,以钙离子依赖的方式被修饰成瓜氨酸残基。在我们以前的报告中,PAD2主要在大鼠大脑中表达,在神经退行性变过程中早期被激活。为了阐明蛋白质瓜氨酸在人类神经元变性中的作用,我们研究了在阿尔茨海默病(AD)期间是否产生了瓜氨酸蛋白。用抗修饰的瓜氨酸抗体进行Western印迹分析,在AD患者的海马区组织中检测到不同分子量的瓜氨酸蛋白,而在正常人的海马区组织中检测到不同分子量的瓜氨酸蛋白。经双向凝胶电泳法和MALDI-TOF质谱仪鉴定,其中两种瓜氨酸蛋白分别为波形蛋白和胶质纤维酸性蛋白。有趣的是,在AD和正常脑的海马区提取液中检测到PAD2,但…AD组织中PAD2表达越多,PAD2含量越高。组织化学分析显示,瓜氨酸蛋白分布于整个海马区,尤其是CA1和CA2区的齿状回和放射层。然而,在正常的海马区没有检测到瓜氨酸蛋白。PAD2免疫反应在AD和正常海马区也普遍存在。PAD2的富集与瓜氨酸蛋白的阳性反应很好地吻合。双重免疫荧光染色显示,瓜氨酸蛋白和PAD2阳性细胞也与GFAP阳性细胞一致,但并非所有GFAP阳性细胞都PAD2阳性。与星形胶质细胞特异性标记蛋白GFAP一样,PAD2主要分布在星形胶质细胞中。AD患者海马区瓜氨酸蛋白的异常积聚和PAD2的异常激活,有力地提示PAD在AD的发生发展中起着重要作用,瓜氨酸蛋白可能成为人类神经退行性疾病的有用标记物。较少
英文摘要
Citrullinated proteins are the products of a post-translational process in which arginine residues undergo modification into citrulline residues when catalyzed by peptidylarginine deiminases (PADs) in a calcium ion-dependent manner. In our previous report, PAD2 expressed mainly in the rat cerebrum became activated early in the neurodegenerative process. To elucidate the involvement of protein citrullination in human neuronal degeneration, we examined whether citrullinated proteins are produced during Alzheimer's disease (AD). By Western blot analysis using anti-modified citrulline antibody, citrullinated proteins of varied molecular weights were detected in hippocampal tissues from patients with AD but not normal humans. Two of the citrullinated proteins were identified as vimentin and glial fibrillary acidic protein (GFAP) by using two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry. Interestingly, PAD2 was detected in hippocampal extracts from AD and normal brains, bu … More t the amount of PAD2 in the AD tissue was markedly greater. Histochemical analysis revealed citrullinated proteins throughout the hippocampus, especially in the dentate gyrus and stratum radiatum of CA1 and CA2 areas. However, no citrullinated proteins were detected in the normal hippocampus. PAD2 immunoreactivity was also ubiquitous throughout both the AD and normal hippocampal areas. PAD2-enrichment coincided well with citrullinated protein-positivity. Double immunofluorescence staining revealed that citrullinated protein- and PAD2-positive cells also coincided with GFAP-positive cells, but not all GFAP-positive cells were positive for PAD2. Like GFAP, which is an astrocyte-specific marker protein, PAD2 is distributed mainly in astrocytes. These collective results, the abnormal accumulation of citrullinated proteins and abnormal activation of PAD2 in hippocampi of patients with AD, strongly suggest that PAD has an important role in the onset and progression of AD and that citrullinated proteins may became a useful marker for human neurodegenerative diseases. Less
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.14670/hh-21.1151
发表时间:
2006-11
期刊:
Histology and histopathology
影响因子:
2
作者:
[W. Yumura;T. Imasawa;S. Suganuma;A. Ishigami;S. Handa;S. Kubo;K. Joh;N. Maruyama]
通讯作者:
W. Yumura;T. Imasawa;S. Suganuma;A. Ishigami;S. Handa;S. Kubo;K. Joh;N. Maruyama
DOI:
10.1073/pnas.0511225103
发表时间:
2006-04-11
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子:
11.1
作者:
[Kondo, Y, Inai, Y, Ishigami, A]
通讯作者:
Ishigami, A
抗MuSK抗体陽性重症筋無力症の病因と病態
抗MuSK抗体阳性重症肌无力的病因和病理
DOI:
--
发表时间:
2006
期刊:
基礎老化研究 30
影响因子:
--
作者:
[重本和宏, 久保幸穂, 丸山直記]
通讯作者:
丸山直記
蛋白質のシトルリン化と病態
蛋白质瓜氨酸化和病理学
DOI:
--
发表时间:
2005
期刊:
最新医学 60
影响因子:
--
作者:
[丸山直記, 石神昭人]
通讯作者:
石神昭人
アルツハイマー病でのシトルリン化蛋白質の異常な蓄積
阿尔茨海默病中瓜氨酸蛋白的异常积累
DOI:
--
发表时间:
2005
期刊:
日本未病システム学会雑誌 11
影响因子:
--
作者:
[Takeshita M, et al., 石神昭人 他]
通讯作者:
石神昭人 他
共 11 条
Analysis of pathogenic mechanisms of myasthenia gravis.
-
批准号:19590374
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:KUBO Sachiho
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: